您的位置: 首页 > 农业专利 > 详情页

Sparstolonin B based pharmaceutical agent for neuroblastoma treatment
专利权人:
发明人:
Ambrish Kumar,Ugra Sen Singh,Daping Fan,Donald J. Dipette
申请号:
US14483445
公开号:
US09446019B2
申请日:
2014.09.11
申请国别(地区):
US
年份:
2016
代理人:
摘要:
Use of sparstolonin B in inhibition of growth and/or viability of human neuroblastoma cells is described. The sparstolonin B can be naturally derived from the Chinese herb Sparganium stoloniferum or can be synthetic. The sparstolonin B is shown to be effective both in vitro and in vivo in inhibition of growth and/or viability of neuroblastoma cells of multiple different genetic backgrounds including N-myc amplified with wild p53 neuroblastoma cells, N-myc amplified with mutated p53 neuroblastoma cells, and N-myc nonamplified neuroblastoma cells.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充